Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14766258 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
Condition: Cervical Cancer
Interventions: Biological: filgrastim;   Drug: paclitaxel;   Drug: topotecan hydrochloride

Indicates status has not been verified in more than two years